De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Marchex Beheer

Beheer criteriumcontroles 1/4

De CEO Marchex's is Edwin Miller, benoemd in Feb2023, heeft een ambtstermijn van 1.67 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 1.50M, bestaande uit 25.8% salaris en 74.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.52% van de aandelen van het bedrijf, ter waarde $ 421.50K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.5 jaar en 7.2 jaar.

Belangrijke informatie

Edwin Miller

Algemeen directeur

US$1.5m

Totale compensatie

Percentage CEO-salaris	25.8%
Dienstverband CEO	1.7yrs
Eigendom CEO	0.5%
Management gemiddelde ambtstermijn	1.5yrs
Gemiddelde ambtstermijn bestuur	7.2yrs

Recente managementupdates

Recent updates

Marchex, Inc. (NASDAQ:MCHX) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Aug 05

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

Mar 01

Is Marchex (NASDAQ:MCHX) In A Good Position To Deliver On Growth Plans?

Oct 19

What You Can Learn From Marchex, Inc.'s (NASDAQ:MCHX) P/SAfter Its 26% Share Price Crash

Sep 14

Analyse CEO-vergoeding

Hoe is Edwin Miller's beloning veranderd ten opzichte van Marchex's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	-US$5m
Mar 31 2024	n/a	n/a	-US$7m
Dec 31 2023	US$1m	US$386k	-US$10m

Compensatie versus markt: De totale vergoeding ($USD 1.50M ) Edwin } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 677.23K ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Edwin te vergelijken met de prestaties van het bedrijf.

CEO

Edwin Miller (54 yo)

1.7yrs

Tenure

US$1,499,136

Compensatie

Mr. Edwin A. Miller serves as Chief Executive Officer of Marchex, Inc. since February 03, 2023. He founded 9Lenses LLC in 2010 and serves as its Chief Executive Officer. He served as President, Chief Execu...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Russell Horowitz	Executive Chairman	7.2yrs	US$537.43k	13.14% $ 10.6m
Edwin Miller	Chief Executive Officer	1.7yrs	US$1.50m	0.52% $ 421.5k
Michael Arends	Vice Chairman & Principal Accounting Officer	1.7yrs	US$530.62k	3.35% $ 2.7m
Holly Aglio	Chief Financial Officer	less than a year	US$630.75k	0% $ 0
Troy Hartless	Chief Revenue Officer	1.5yrs	US$978.50k	0% $ 0
Trevor Caldwell	Senior Vice President of Investor Relations & Strategic Initiatives	no data	geen gegevens	geen gegevens
Lyall Vanatta	Vice President of Marketing	less than a year	geen gegevens	geen gegevens
Julie Warner	Vice President of People Services	no data	geen gegevens	geen gegevens
Matt Muilenburg	Chief Market Development Officer	no data	geen gegevens	geen gegevens
Todd Wilson	Senior VP of Product	no data	geen gegevens	geen gegevens
Cullen Davidson	Senior Vice President of Engineering	less than a year	geen gegevens	geen gegevens
Francis Feeney	Chief Corporate & Strategic Affairs Officer and Company Secretary	no data	geen gegevens	geen gegevens

1.5yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van MCHX wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.5 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Russell Horowitz	Executive Chairman	7.2yrs	US$537.43k	13.14% $ 10.6m
Michael Arends	Vice Chairman & Principal Accounting Officer	1.7yrs	US$530.62k	3.35% $ 2.7m
Dennis Cline	Independent Director	21.4yrs	US$68.60k	0.27% $ 221.1k
M. Wisehart	Independent Director	15.9yrs	US$68.60k	0.75% $ 600.5k
Donald Cogsville	Independent Director	5.5yrs	US$68.60k	0.21% $ 169.5k

7.2yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MCHX wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.2 jaar).

Marchex Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Chief Executive Officer recently bought US$272k worth of stock

Marchex, Inc., Annual General Meeting, Sep 28, 2023

Marchex, Inc. Announces Executive Changes

Insufficient new directors

Recent updates

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Marchex, Inc., Annual General Meeting, Oct 30, 2024

Consensus EPS estimates upgraded to US$0.085 loss

Second quarter 2024 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2024

Marchex, Inc. (NASDAQ:MCHX) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Marchex, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Chief Executive Officer recently bought US$272k worth of stock

New minor risk - Shareholder dilution

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Marchex, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2024

Marchex, Inc. to Report Q1, 2024 Results on May 07, 2024

Marchex Launches Generative Ai-Powered Sentiment Suite Across Multiple Apis

Consensus EPS estimates upgraded to US$0.12 loss, revenue downgraded

Full year 2023 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year of 2024

Marchex, Inc. to Report Q4, 2023 Results on Mar 14, 2024

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

Third quarter 2023 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for Fourth Quarter Ending December 31, 2023 and Fiscal Year 2024

New major risk - Revenue and earnings growth

Marchex, Inc. Launches Call Summary and Sentiment Suite Capabilities for Vertical Markets

Marchex, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Is Marchex (NASDAQ:MCHX) In A Good Position To Deliver On Growth Plans?

What You Can Learn From Marchex, Inc.'s (NASDAQ:MCHX) P/SAfter Its 26% Share Price Crash

Marchex, Inc., Annual General Meeting, Sep 28, 2023

New major risk - Financial position

Second quarter 2023 earnings: EPS exceeds analyst expectations

Companies Like Marchex (NASDAQ:MCHX) Are In A Position To Invest In Growth

Consensus EPS estimates fall by 29%

First quarter 2023 earnings: EPS misses analyst expectations

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 66%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.1% to US$3.25

Marchex, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Marchex, Inc. Announces Executive Changes

We're Not Very Worried About Marchex's (NASDAQ:MCHX) Cash Burn Rate

Insufficient new directors

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Marchex, Inc. to Report Q3, 2022 Results on Nov 03, 2022

We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely

Marchex, Inc., Annual General Meeting, Sep 29, 2022

Consensus forecasts updated

Second quarter 2022 earnings: EPS exceeds analyst expectations

Marchex, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Insufficient new directors

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Second Quarter of 2022

Marchex, Inc. to Report Q1, 2022 Results on May 12, 2022

Insufficient new directors

Price target decreased to US$3.50

We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Marchex Inc. Launches Conversation Dna, Delivering Powerful Ai Signals Through Every Marchex Conversation Intelligence Product

Marchex, Inc. to Report Q4, 2021 Results on Mar 02, 2022

Price target decreased to US$4.00

Third quarter 2021 earnings released: EPS US$0.083 (vs US$0.078 loss in 3Q 2020)

Marchex: Hope Springs Eternal

Second quarter 2021 earnings released: US$0.008 loss per share (vs US$0.096 loss in 2Q 2020)

Does Marchex (NASDAQ:MCHX) Have A Healthy Balance Sheet?

Consensus EPS estimates increase to -US$0.29

Consensus EPS estimates increase to -US$0.44

First quarter 2021 earnings released: US$1.14 loss per share (vs US$0.53 loss in 1Q 2020)

Marchex, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2021

Marchex® Launches AI-powered SalesEngagement Solution

Is Marchex (NASDAQ:MCHX) Using Debt Sensibly?